183 related articles for article (PubMed ID: 17184743)
1. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Rosenberg GA; Estrada EY; Mobashery S
Brain Res; 2007 Feb; 1133(1):186-92. PubMed ID: 17184743
[TBL] [Abstract][Full Text] [Related]
2. Early beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brain.
Sood RR; Taheri S; Candelario-Jalil E; Estrada EY; Rosenberg GA
J Cereb Blood Flow Metab; 2008 Feb; 28(2):431-8. PubMed ID: 17700631
[TBL] [Abstract][Full Text] [Related]
3. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Pfefferkorn T; Rosenberg GA
Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
Rosenberg GA; Estrada EY; Dencoff JE
Stroke; 1998 Oct; 29(10):2189-95. PubMed ID: 9756602
[TBL] [Abstract][Full Text] [Related]
5. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.
Fujimura M; Gasche Y; Morita-Fujimura Y; Massengale J; Kawase M; Chan PH
Brain Res; 1999 Sep; 842(1):92-100. PubMed ID: 10526099
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
Yang Y; Estrada EY; Thompson JF; Liu W; Rosenberg GA
J Cereb Blood Flow Metab; 2007 Apr; 27(4):697-709. PubMed ID: 16850029
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Ricci S; Grandgirard D; Wenzel M; Braccini T; Salvatore P; Oggioni MR; Leib SL; Koedel U
BMC Infect Dis; 2014 Dec; 14():726. PubMed ID: 25551808
[TBL] [Abstract][Full Text] [Related]
10. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
Walker EJ; Rosenberg GA
Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
[TBL] [Abstract][Full Text] [Related]
11. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat.
Nagel S; Genius J; Heiland S; Horstmann S; Gardner H; Wagner S
Brain Res; 2007 Feb; 1132(1):210-7. PubMed ID: 17184751
[TBL] [Abstract][Full Text] [Related]
12. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.
Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ
Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651
[TBL] [Abstract][Full Text] [Related]
13. [Exploration of the effect of inhibitor of matrix metalloproteinase-9 on blood brain barrier in cardiopulmonary resuscitation in rats].
He ZJ; Zou ZJ; Chen XT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):337-9. PubMed ID: 19570337
[TBL] [Abstract][Full Text] [Related]
14. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Sumii T; Lo EH
Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
[TBL] [Abstract][Full Text] [Related]
15. Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor.
Maquoi E; Sounni NE; Devy L; Olivier F; Frankenne F; Krell HW; Grams F; Foidart JM; Noël A
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4038-47. PubMed ID: 15217936
[TBL] [Abstract][Full Text] [Related]
16. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke.
Machado LS; Kozak A; Ergul A; Hess DC; Borlongan CV; Fagan SC
BMC Neurosci; 2006 Jul; 7():56. PubMed ID: 16846501
[TBL] [Abstract][Full Text] [Related]
17. Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.
Lee M; Chen Z; Tomlinson BN; Gooyit M; Hesek D; Juárez MR; Nizam R; Boggess B; Lastochkin E; Schroeder VA; Wolter WR; Suckow MA; Cui J; Mobashery S; Gu Z; Chang M
ACS Chem Neurosci; 2015 Oct; 6(10):1658-64. PubMed ID: 26241578
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood-brain barrier dysfunction in an animal model of severe sepsis.
Dal-Pizzol F; Rojas HA; dos Santos EM; Vuolo F; Constantino L; Feier G; Pasquali M; Comim CM; Petronilho F; Gelain DP; Quevedo J; Moreira JC; Ritter C
Mol Neurobiol; 2013 Aug; 48(1):62-70. PubMed ID: 23479197
[TBL] [Abstract][Full Text] [Related]
19. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.
Kikuchi DS; Campos ACP; Qu H; Forrester SJ; Pagano RL; Lassègue B; Sadikot RT; Griendling KK; Hernandes MS
J Neuroinflammation; 2019 Nov; 16(1):241. PubMed ID: 31779628
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
Chastre A; Bélanger M; Nguyen BN; Butterworth RF
Liver Int; 2014 Mar; 34(3):353-61. PubMed ID: 23910048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
